Upcoming Conference, to be held April 8th, 2005, Provides Compelling New Thoughts on Pharmaceutical and Medical Device Marketing
Agency.com, Alliance Healthcare Information, BBDO, Hall & Partners Healthcare, and Targetbase are sponsoring an upcoming conference, Can Pharmaceutical and Medical Device Marketers Learn From the Automobile Industry? Yes...here's why.
Upcoming Conference, to be held April 8th, 2005, Provides Compelling New Thoughts on Pharmaceutical and Medical Device Marketing
Agency.com, Alliance Healthcare Information, BBDO, Hall & Partners Healthcare, and Targetbase are sponsoring an upcoming conference, Can Pharmaceutical and Medical Device Marketers Learn From the Automobile Industry? Yes...here's why. The conference will be held on Friday, April 8, 2005, at the Hyatt Regency Princeton, Princeton, New Jersey.
The conference will introduce many new and incisive thoughts regarding how Pharmaceutical and Medical Device companies can learn from other industries' best practices as they relate to DTC, more targeted communications, and compliance. Topics covered will include:
- The purchase process, as identified and defined by the automobile industry through extensive research, and an explanation of its resemblance to the pharmaceutical and medical device purchase process.
- Building awareness and interest via pharmaceutical DTC advertising and how DTC's role parallels that of automotive national advertising.
- How the healthcare industry can leverage proven direct and database marketing strategies that are being successfully deployed in the automobile industry today.
- What common threads exist when building brands in the pharmaceutical and automotive spheres.
Upcoming/Add one
- The comparable roles of cyberspace in the two equations.
- How considered purchase service programs are similar to pharmaceutical compliance/adherence programs.
An expert lineup of speakers will feature Lewis G. Pringle, PhD, former EVP and Research Director of BBDO Worldwide and holder of the Chair of Marketing at Miami of Ohio University, currently Chairman of the Department of Managerial Economics and Professor of Marketing at Yorktown University; Thomas Abrams, R.Ph., MBA, Director, Branch Chief Marketing & Surveillance Branch 1 with DDMAC of the FDA; as well as other industry experts in the pharmaceutical and automobile markets.
The conference is free, by INVITATION ONLY, and will include breakfast and lunch. If you are interested in this conference and would like to be added to the invitation mailing list, please e-mail Sarah Schaeffer, sschaeffer@alliancehealthinfo.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
